Neurons are functionally segregated into discrete populations that perform specific 30 computations. These computations, mediated by neuron-neuron electrochemical signaling, form 31 the neural basis of behavior. Thus, fundamental to a brain-based understanding of behavior is 32 the precise determination of the contribution made by specific neurotransmitters to behaviorally 33 relevant neural activity. To facilitate this understanding, we have developed a cannulated 34 microelectrode array for use in behaving rats that enables simultaneous neural ensemble 35 recordings and local infusion of drugs in the same brain nucleus. The system is inexpensive and 36 easy to use, and produces robust and quantitatively reproducible drug effects on recorded 37 neurons. 38
INTRODUCTION 42
Determining how a neural circuit produces behavior requires two key steps: demonstration that 43 neurons in a circuit encode behaviorally relevant information, and demonstration that disruption 44 or activation of this encoding influences behavior. The first step is accomplished by recording 45 the firing of neurons in behaving animals, but the second step is more complicated. Behavioral 46 pharmacology methods (introduction of biologically active substances, such as neurotransmitter 47 blockers, into specific brain areas of behaving animals) provide powerful means for assessing 48 the contribution of a brain nucleus to specific behaviors, but pharmacological studies are 49 typically performed separately from electrophysiological studies. This means that the 50 connections leading from a neurotransmitter's action to neuronal firing to behavior are usually 51 established with evidence that is, at best, circumstantial. Thus, neural circuit analysis would 52 benefit from a reliable method for directly determining how receptor activation contributes to 53 neuronal encoding. Here, we describe a technique for localized pharmacological treatment of 54 neurons recorded in behaving rodents. 55
Reverse microdialysis, iontophoresis and pressure injection are the three most widely used 56 methods for acute in vivo delivery of drugs to discrete brain regions. Each approach offers a 57 unique set of advantages and drawbacks with respect to its use with concurrent 58 electrophysiological recording of the treated neurons. Paired recording and iontophoresis 59 probes have been used in awake behaving animals (Cheer et al. 2007; Haidarliu et al. 1999; 60 Kiyatkin and Rebec 1996a , b, 1997 , 1998 , 1999a , b, 2000 Sawaguchi 1997 ; Sawaguchi et al. 61 1990; West and Woodward 1984; Williams and Goldman-Rakic 1995). These systems use 62 electrical current to eject small quantities of drugs from a multi-barreled glass pipette, which is 63 also used to record neuronal activity. An advantage of this technique is that drug effects are 64 highly localized to the area near the recorded neuron. However, iontophoresis in freely moving 65 rats is technically difficult due to the fragility of the glass pipette and the tendency of the small 66 5 1999). These results suggest that pressure injection can be used to treat locally recorded 92 neurons with drugs, but complete details regarding the fabrication and testing of these hybrid 93 systems have either not been reported, or have been reported but not tested (Greger et al. 94 2007) . 95
If the problem of displacement of neural tissue can be overcome, the pressure injection 96 technique has a major advantage over iontophoresis and microdialysis: microinjections are easy 97 to perform. Here, we report that when appropriate injection rates are used, drug effects are 98 extremely consistent and loss of recorded neurons is minimal. We provide complete methods 99 for the construction of a versatile, inexpensive, light-weight, and easy-to-use microwire 100 electrode array surrounding a central microinjection cannula, including a microdrive that allows 101 chronic implantation in rat or mouse brain. The microdrive provides a stable, simple and 102 inexpensive ($8 per drive) platform for microwire array recordings with or without inclusion of an 103 injection cannula. Construction procedures for the entire system are extremely simple, and yet 104 result in cannulated arrays and microdrives with physical parameters that are highly replicable. 105
We demonstrate that this system results in highly reproducible effects of lidocaine on the firing 106 of neurons in the nucleus accumbens (NAc) of awake, unrestrained rats. 107 6 manufacturing company (American Precision Prototyping), which produces the components. 116
The hub consists of a block of ABS plastic (11.2 mm in height, 3 mm thick, and 6.95 mm wide) 117 containing two holes for 17 ga hypodermic tubes and a central hole for the drive mechanism (a 118 brass press insert with internal threads, and a stainless steel 0-80 socket-head screw) ( Fig. 1) . 119
The hub will be secured to the animal's skull, and one of the 17 ga tubes (the drive tube) will 120 contain the electrodes and microinjection guide cannula. The plastic hub also includes a ring-121 shaped protrusion (protective collar) surrounding the drive tube. During electrode/cannula 122 implantation, the protective collar will extend just below the level of the dura before the drive is 123 cemented in place; the protective collar thus serves to protect the drive mechanism from the 124 cement. The drive stage (3.175 mm height, 3 mm thick and 6.95 mm wide) is secured to the 125 electrodes and microinjection cannula and can be driven downwards relative to the base and 126 skull (to move the cannula and electrodes through the brain tissue). Both the drive hub and 127 stage are rounded at one end to reduce their bulk, facilitating dual placements in nearby brain 128 regions (e.g., left and right NAc core). 129
To construct the microdrive, the hole at the bottom of the protective collar ( Fig. 1A) is drilled out 130 7 epoxy (Devcon, 5 Minute Epoxy) is applied liberally to attach the drive tube, mount tube, flat 141 washer and retaining rings to the drive stage, and to attach the brass insert to the hub (blue 142 stars in Fig. 1 ). Finally, the drive and mount tubes are cut so that when the drive stage is fully 143 driven towards the hub, the drive tube extends 3-4 mm below the protective collar, and the 144 mount tube is flush with the bottom of the hub. 145
Jig: To precisely mount the cannula and electrodes in the microdrive, we first construct a jig (a 146 device that holds components in place so that they can be mounted in the microdrive) ( Fig.1B) . 147
The jig is made from stainless steel hypodermic tubes and can be reused to ensure that the 148 positioning of the probe components is reproduced accurately. To construct the jig, one cannula 149 guide (23 ga hypo tube) and eight electrode guide tubes (31 ga hypo tubes) are cut to a length 150 of 8 mm with a diamond tipped cutting wheel mounted on a rotary tool (e.g., Dremel ® ). To 151 prevent clogs, a tungsten rod is inserted into each of the electrode guide tubes before they are 152 trimmed to 8 mm. The jig components are placed on a piece of flat wax paper and a thin layer of 153 Krazy glue is applied to the cannula guide. Two electrode guide tubes are then quickly pushed 154 into the glue so that they are positioned flush against the cannula guide. Small amounts of 155 modeling clay can be used as spacers between the remaining electrode guides, which are 156 sequentially arrayed around the central cannula guide. Finally, the jig is embedded in the jig 157 sleeve (17 ga hypodermic tube) using two-ton epoxy. 158
Microwire electrodes and guide cannulae: We use spooled Teflon-coated tungsten microwire for 159 our neural recordings because of its low cost (Table 2) , rigidity and high tensile strength. We 160 tested several types of spooled wire and found that tungsten reliably yields robust, well-isolated 161 single unit recordings. Electrodes are prepared by cutting 8 cm segments of the tungsten wire. 162
Approximately 1 mm of insulation is then stripped from one end of each wire using fine-tipped 163 forceps. The stripped end is clipped to the terminal of an impedance meter using a micro-164 plunger test lead. The wire is held so it is parallel to the table and cut at a 90º angle with 165 serrated electrode scissors (Fine Science Tools, 14058-09). The wires yielding the best 166 recordings are cut as flat and quickly as possible. The recording tip is then submerged in 0.9% 167 normal saline and the impedance is measured (1000 Hz, 10 nA) several times to ensure a 168 stable impedance measurement of ~100 kΩ. If necessary, the recording tip is repeatedly cut 169 until the target impedance is achieved. 170
To prepare the guide cannula, a 27 ga hypodermic tube is cut to a length of 30 mm using a 171 diamond-tipped cutting wheel mounted on a rotary tool and then deburred by twisting a syringe 172 needle inside the tube. During experiments, a 33 ga injector cannula will be inserted into the 173 guide cannula. Preliminary experiments found that a 0.5 mm extension of the injector beyond 174 the tip of the guide cannula (extending into the brain) greatly attenuates neuron loss caused by 175 tissue displacement compared with longer (1-2 mm) extensions. This arrangement results in a 176 ~670 μm distance between the center of the microinjector tip and center of each recording 177 electrode. To achieve a precise and consistent difference in lengths of the injector and guide 178 cannula, injectors are cut by placing the microinjector into a pre-cut 30 mm 27 ga hypodermic 179 tube and grinding it to a length of 30.5 mm with a diamond-tipped cutting wheel. A metal 180 precision ruler is useful to assure the accuracy of the cut. Each injector is deburred by repeated 181 twisting of a 30 ga syringe needle in the injector tube. 182
Mounting the array in the microdrive: We use two linear translators and a rotation mount to 183 install the array into the microdrive ( Fig. 2A) , although a stereotaxic instruments with two 184 positioning arms can also be used. The XYZ translator (THORLABS model PT3) holds the 185 microdrive and allows small adjustments to be made in all three dimensions, facilitating precise 186 alignment of the microdrive with the jig. The Z translator (THORLABS model LT1) holds a 187 platform on which the electrodes and microinjection guide cannula rest; this moves only in the z 188 dimension. Finally, the rotation mount (THORLABS model RSP05) holds the jig and facilitates 9
The screw in the drive is first turned to move the drive stage down towards the drive hub as far 191 as possible. The microdrive is then mounted on the arm of the XYZ translator, and the jig is 192 mounted on the rotation mount and positioned above the platform held by the Z translator (Fig. 193 2A). Next, a 27 ga cannula, pre-cut to a length of 30 mm, is placed into the cannula guide of the 194 jig, and 8 tungsten microwires (prepared as described above), with recording tips up (away from 195 the platform), are inserted into the jig's electrode guide tubes (Fig. 2B ). The jig is then slowly 196 and carefully rotated 180 degrees, so that the recording tips rest gently on the moveable 197 platform. Next, the electrodes are carefully pushed through the microdrive drive tube ( The microdrive is then raised several millimeters, taking care that the microwires and cannula 205 remain in their respective jig guide tubes. A syringe needle is then used to apply several drops 206 of epoxy at the point where the electrodes protrude from the bottom of the microdrive drive tube 207 ( Fig. 2E ), being careful not to spill epoxy onto the jig or the outside of the drive tube. Typically, 208 the epoxy will be drawn upwards into the drive tube by capillary action; several applications of 209 epoxy assure that the electrodes and microinjection cannula are securely embedded in the drive 210 tube. After the epoxy hardens for ~15 min, the array is removed from the jig and the epoxy is 211 allowed to completely harden overnight. This procedure results in the microwires and cannula 212 held securely in the configuration determined by the jig. The length of the microwires below the 213 protective collar on the drive hub is identical to the length of the jig (8 mm); this length is 214 appropriate to reach targets ranging from the most dorsal (cortex) to ventral (e.g., ventral 215 pallidum). Finally, the microwires and a bare silver wire ground electrode are soldered to a 216 connector (e.g., Omnetics) appropriate for the recording system, and the soldered connections 217 are embedded in epoxy. 218
Animals: Eight male Long-Evan rats (~275-300 g on arrival) were obtained from Charles River 219 and singly housed. One week after their arrival, animals were handled for several minutes daily 220 for 1 week to habituate them to handling. All animal procedures were consistent with the U. (10 mg/kg, i.p) and maintained with isoflurane (.5-3%). Animals received 60,000 U/kg penicillin-228 G antibiotic the evening before surgery, just prior to surgery, and 12 hr after surgery. After 229 surgery, the scalp was treated with Neo-Predef to prevent infection and the animals were 230 allowed one week of recovery before proceeding with experiments. For post-surgery analgesia, 231 animals were given 10 mg/kg of the non-steroidal anti-inflammatory drug Ketoprofen. 232 Cannulated arrays were implanted bilaterally into the dorsal NAc core (1.4 mm anterior and ±1.5 233 mm lateral from bregma, and 6.5 mm ventral from the skull) using the following procedure. 234
Bone screws are first affixed to the skull, and a craniotomy above the target structure is 235 performed. The dura is then removed. Prior to mounting the microdrive on the moveable arm of 236 the stereotaxic instrument, the stage is driven upwards from the hub such that when the drive 237 hub rests on the top of the skull, the protective collar extends into the craniotomy to just below 238 the surface of the brain and the electrodes are at their intended target. To mount the drive in the 239 stereotaxic instrument, an 18 ga syringe needle is inserted into a collet electrode holder (Kopf 240 instruments) mounted on a moveable stereotaxic arm. This syringe needle is then inserted into 241 the empty mount tube (Fig. 1A ) of the microdrive, which is then aligned so that it is lengthwise in 242 the sagittal plane. A small amount of bone wax can be placed in the bottom of the mount tube to 243 prevent intrusion of dental cement during implantation. 244
The electrodes and cannula are lowered through the brain to just dorsal to the target structure. 245
The drive is then embedded in acrylic cement, which does not impede movement of the 246 cannula/electrodes because the protective collar surrounds these components above the brain 247 surface. The silver wire is implanted on the posterior cortical surface for use as a ground 248 electrode. The reservoir bulb of a plastic transfer pipette (Fisherbrand, polyethylene, 13-711-249 7M) is cut from the pipette shaft, placed over the microdrives as a protective cover, and 250 embedded in cement. A small window is cut into the severed bulb to provide access to the 251 microdrive mechanism and cannulae. An electrical connector is also embedded in the cement. Table 2 ), along the recording cable to 260 the animal's head. The recording cable is purchased with a protective metal coil (Plexon, Inc., 261 HSC/165o-G1-R00-L2A1B-2), which is then wrapped in Silastic tubing and secured with 262 electrical tape and miniature cable ties. This arrangement provides rigidity to prevent twisting of 263 the recording cable when it is attached to the connectors embedded in acrylic cement on the 264 female counterpart attached to the commutator (Fig. 3) . To attach the DB25 connector to the 266 commutator, the cable hole of the DB25 casing is widened to 1.25 cm using a drill press. Then, 267 a 2.5 cm lengthwise window is cut in a 1.25 cm diameter, 5.4 cm hollow link tube, which is 268 inserted 1 cm into the neck of the DB25 case. A hole is drilled through both the DB25 case and 269 the link tube, which are then secured to one another with a screw embedded in two-ton epoxy. 270
To mount this assembly on the commutator, the link tube is inserted into the commutator bore 271 hole, so that it protrudes 2 cm above the top lip of the commutator. This link tube is then 272 attached to the commutator lip using a shaft collar. Next, a screw is inserted through the shaft 273 collar above the level of the commutator. Before the nut of this screw is tightened, a stiff piece of 274 wire is wrapped several times around the screw and is connected to the spring tether mount on 275 the fluid swivel. Then the nut is tightened. This arrangement creates strong direct coupling 276 between the counterbalance arm, commutator and fluid swivel, so that they rotate together as 277 the animal moves about the chamber. 278
The recording cable is attached to a counterbalance arm, which is constructed from a 23 cm 279 length of 8 ga hypodermic tube suspended with a wire hinge from the DB25 connector on the 280 commutator ( Fig. 3 ). Small round spacers are placed at the bend of the hinge to prevent shifting 281 of the counterbalance arm relative to the hinge. A 10 cm window is cut into the counterbalance 282 arm, which allows the recording cable to fit securely inside. This arrangement strongly tethers interface was marked to enable post-hoc confirmation that the drug was injected. To prepare 296 animals for neural recording and injection, obturators were removed and the recording cable 297 was plugged into the electrical connector on the animal. The animal was gently restrained while 298 the microinjectors (loaded with drug) were inserted into the animal's guide cannulae. 299
We recorded pre-injection baseline firing rates lasting 2-20 min, after which the syringe pump 300 was activated either manually or by a programmed electronic signal. Flow rates were optimized 301 in pilot studies prior to these experiments. We found that flows > 0.06 μl/min resulted in a low 302 yield of neurons in subsequent more ventral recordings, and that this problem was eliminated by 303 slowing the rate of injection. Therefore, we used a flow rate of 0.046 μl/min in these 304 experiments. Over 12 min, we injected 0.55 μl of freshly prepared 5% lidocaine hydrobromide 305 monohydrate (Sigma-Aldrich) dissolved in 0.9% normal saline, or saline alone as a control. 306
Recordings continued for 30-45 min after the injection so we could assess drug effects and 307 recovery. After the experiment, the microdrive carrying the electrode arrays was advanced ~160 308 μm in order to obtain a new set of neurons for the next experiment two days later. 309
We recorded from 181 neurons in 36 recording/injection sessions. The voltage signals were 310 amplified and filtered, and neural spikes detected and sorted, as previously described 311 To determine the latency of lidocaine effects across the electrode array, 1 sec bins were used to 325 calculate the PDF of the pre-injection baseline period. Because smaller bins were used than for 326 the previous analysis, the lower tail of the 99% confidence interval of the baseline firing rate 327 spanned zero in some neurons (i.e., those with very low firing rates). These 39 neurons (out of 328 100 affected by lidocaine) were discarded for the latency analysis. The time of onset of the drug 329 effect was determined as the first bin of at least 60 consecutive bins with spike counts below the 330 lower 99% confidence interval of the baseline period. To analyze the variability in latency to 331 onset of lidocaine's effects across neurons recorded in individual sessions, we determined 332 which neuron in each session first demonstrated a lidocaine-induced reduction in firing rate (as 333 defined above) and then calculated the latency between this neuron's drug onset time and those 334 of the other neurons recorded from the same hemisphere. 335
To determine the fraction of neurons that recovered from the effects of lidocaine, 1 min bins 336 were constructed and the spike count for the last complete bin in each session was calculated 337 from lidocaine treatment was determined by isolating the time at which the firing rate of affected 339 neurons returned to a value greater than the lower limit of the 99% confidence interval. 340
341

RESULTS
342
To characterize the effectiveness of the cannulated array system, we performed a series of 343 microinjections of the Na + channel blocker lidocaine into the NAc core to determine flow rates 344 and volumes that produce efficient diffusion of drugs to recorded neurons. We chose lidocaine 345 because recovery from its effects tends to be rapid (Hille 1966; Sandkuhler et al. 1987; 346 Tehovnik and Sommer 1997), enabling us to differentiate drug effects from displacement of the 347 neuron from the recording electrode. We determined that 0.55 μl of 5% lidocaine dissolved in 348 saline, injected over 12 min, resulted in reductions in firing rate that were temporally and 349 quantitatively similar across neurons recorded from electrodes surrounding the injection site. changed just prior to the lidocaine-induced elimination of spiking (Fig. 4C ). Both the peak 358 amplitude and initial slope of the waveforms decreased, and recovered when firing rate returned 359 to baseline. In contrast, saline injections caused no observable changes in waveform shape 360 ( Fig. 4D) . Effects of lidocaine similar to those described in Fig. 4A (firing rate reduced below the 361 99% confidence interval of the baseline for ≥ 60 sec) were observed in 100 out of 105 neurons 362 (95.2%) during 19 simultaneous recording and lidocaine injection sessions ( Fig. 4E ). Of these 363 100 neurons, 68 recovered to within the 95% confidence interval of their pre-injection baseline 364 firing rates computed from 1 min bins (Fig. 4F ). Only 15 of the 100 neurons failed to 365 demonstrate any appreciable recovery (remaining at 0 -10% of baseline by the end of the 366 recording session).Excluding these 15 neurons, there was no significant difference between the 367 mean firing rate of affected neurons during the pre-injection baseline (mean±SEM: 4.4 ± 0.44 368 Hz) and the recovery period (4.3 ± 0.4 Hz) (t 84= 0.16, p=0.6, n=85). On average, lidocaine effects 369 lasted 11.5±1.4 min (n=70 neurons). In contrast, saline injections reduced the firing of only 6 of 370 76 neurons (7.9%) recorded during 17 injections (Fig. 4E) . These results demonstrate that the 371 recording/microinjection system can be used to obtain robust and reliable drug effects on the 372 vast majority of neurons recorded during the injection. 373
Prior to experiments, the microinjectors (pre-loaded with drug) were inserted into the cannulae 374 before the acquisition of a neural baseline. A major advantage of this approach is that it is 375 unnecessary to unplug the animal to perform an injection. Consequently, neural activity can be 376 continuously monitored before, during and after injection of drugs. However, one potential 377 concern is that lidocaine might leak out of the microinjector prior to activation of the infusion 378 pump, thus preventing the acquisition of a drug-free baseline. Such leakage is unlikely because 379 the fluid system is closed to gravity. Nevertheless, to determine whether lidocaine leaked from 380 the microinjectors prior to activation of the pump, we examined the pre-injection firing rates as a 381 percentage of the average firing rate of the entire baseline period for all 100 neurons that were 382 affected by lidocaine (Fig. 5A) . The baselines were very stable over the entire pre-injection 383 period, which ranged from 2-20 min (baselines of at least 15 min were obtained prior to 13 of 19 384 injections). The lack of a trend towards a reduction in firing rate over time in any neurons during 385 the baseline strongly suggests that, if lidocaine leaked from the microinjector during this period, 386 it did so in quantities insufficient to affect neuronal firing. 387
In many of our initial experiments, the injection pump was started and stopped manually and 388 therefore we do not have precise time stamps for these events. Consequently, we chose a 389 subset of later experiments, conducted with precise electronically-determined injection onset 390 and offset times, to obtain an estimate of the time course of the onset of the lidocaine effect. In 391 these experiments, a 10 min neural firing baseline was obtained, after which the animal was 392 injected with lidocaine or saline. All 12 neurons exposed to lidocaine in 2 injections exhibited a 393 sharp reduction in firing rate that dropped to 0 Hz between 13 and 14 min after the end of the 394 injection, and 8 of these neurons either fully or partially recovered from the injection (Fig. 5B,  395 black traces). There was no effect on any of the 14 neurons exposed to saline in 2 injections 396 ( Fig. 5B, gray traces) . 397
One advantage of our method is that the electrodes are all equidistant from the cannula, so that 398 the time course of the effects of an injected drug should be similar across all recorded neurons. 399
To determine whether lidocaine did in fact reach sampled neurons at the same time, we 400 examined the variability in the latency of lidocaine's effects on firing rate. Within each recording 401 session, the neuron that first showed a lidocaine effect was identified, and the difference in 402 latency to a lidocaine effect relative to this reference neuron's latency was calculated for all 403 other neurons recorded in the same hemisphere. (During 4 sessions, we recorded from only 404 one neuron, and so we were unable to calculate latency differences for these experiments. In 405 addition, 39 out of 100 neurons affected by lidocaine had 99% confidence intervals spanning 406 zero when spike counts were binned at 1 second, and thus were not included in this analysis.) 407
The calculated latency differences were at most 6 sec (Fig. 5C ). We categorized these latencies 408 according to whether they were taken from neurons recorded on the same or different electrode 409 than the reference neuron. There was no statistically significant difference in the latencies 410 between these two groups (t test, p = 0.43), and all 42 calculated latency differences (across 15 411 injections) were < 7 sec. These results indicate that the circular design of the array facilitates 412 temporally uniform diffusion of injected drugs to neurons recorded on all electrodes, with very 413 little variability in the latency to drug onset. 414
415
DISCUSSION 416
This study presents evidence that our novel drivable cannulated electrode array can be used to 417 obtain robust and repeatable effects of drugs injected directly into the vicinity of neurons 418 recorded in freely moving rats. After lidocaine injection into the NAc core, the vast majority of 419 the recorded NAc neurons typically ceased firing entirely, and the majority of the affected 420 neurons (68%) recovered to within the 95% confidence interval of their baseline firing rates. 421
These drug effects were evident ~13.5 min after the end of the injection, they lasted 11.5 min on 422 average, and the onset of the effect was nearly simultaneous in all neurons recorded in the 423 same hemisphere during a given injection. Furthermore, saline injections using identical 424 parameters had no effect on the vast majority of NAc neurons. These results demonstrate that 425 the approach we describe offers a reliable method for the study of the action of pharmacological 426 agents on neural activity in freely moving rats. 427
The diffusion time course and functional spread of intracranially injected lidocaine have been 428 investigated in great detail in restrained or anesthetized monkeys, cats, raccoons, and rats 429 range. Electrophysiological studies show that the strongest effects of 0.5 μl lidocaine injected in 434 the rat brain extend spherically 500 μm from the injector, and that lesser but significant effects 435 are observed up to 1 mm from the injection site (Sandkuhler and Gebhart 1984; Tehovnik and 436 Sommer 1997) . Although our electrodes were farther from the injector than 500 μm, they were 437 also dorsal to the injection site, and our injections were slow. Injection at lower rates is more 438 likely to cause diffusion dorsally (towards the lower pressure area around the injector shaft) prior was longer in our experiments (~13.5 min), but this is likely due to the slower injection rates we 448 used. The long latency to lidocaine effects in this and previous studies is likely attributable to 449 variables such as the low affinity of lidocaine for Na + channels and the requirement that 450 lidocaine molecules diffuse significant distances through the extracellular matrix to reach the 451 point where their action can be observed (the soma of the recorded neurons). 452
Although we used lidocaine for functional tests of our system, our results suggest that other 453 drugs, such as specific receptor blockers, could also be injected. A potential source of concern 454 is the finding that 32% of neurons affected by lidocaine did not recover to within the 95% 455 confidence interval of baseline firing rate, with 15% showing no recovery at all (Fig. 4F) . One 456 possibility is that the pressure injections caused displacement of neural tissue away from the 457 electrodes, such that their firing could no longer be observed even after wash-out of the drug. 458
Arguing strongly against this idea is that saline injections reduced the firing rate of very few 459 neurons (<7%). A more compelling explanation for the failure of recovery from lidocaine 460 injections is that lidocaine is somewhat toxic (Gold et al. 1998; Kanai et al. 1998; Ready et al. 461 1985) . Therefore, injection of less toxic drugs using this system is likely to produce a higher 462 proportion of neurons exhibiting complete recovery of drug effects. 463
The use of drugs other than lidocaine with our system is likely to require some adjustment in 464 injection parameters. Total injection volume, size of the drug molecule, and injection rate are the 465 major factors that determine the spatial extent of drug diffusion in brain tissue (Nicholson 1985; 466 Sykova and Nicholson 2008) . In pilot experiments, we optimized the injection rate to minimize 467 neuron loss and maximize lidocaine effects. A relatively narrow range of flow rates yielded 468 reliable results: with fast injections (0.55 μl in < 8 minutes), a significant number of recorded 469 neurons was lost; with very slow injections (0.55 μl in > 16 minutes), there was no discernible 470 lidocaine effect on recorded neurons (not shown). Injection rates slower than 0.55 μl in 8 min 471 increased the yield of neurons in subsequent experiments (after driving the electrodes and 472 cannula ventrally). This increased yield is likely reflective of a decrease in damage due to 473 distension of brain tissue after rapid introduction of a relatively large volume of perfusate 474 (Demer and Robinson 1982). Thus, injection rates of ~0.046 μl/min appear to be optimal to 475 minimize tissue damage and maximize drug effects. Using this injection rate, the drug 476 concentration and length of injection should be empirically determined to obtain injection 477 parameters for other drugs of interest. In addition, it should be possible to obtain drug effects 478 more prolonged than the 11.5 min observed in our experiments simply by increasing the volume 479 of injection while maintaining a slow injection rate, as observed by others using lidocaine 480 (Tehovnik and Sommer 1997) . 481
The cannulated array described here offers several advantages over existing means for local 482 drug treatment of neurons recorded in behaving animals. Microinjection is a relatively simple 483 procedure compared with microdialysis and iontophoresis, and it requires little specialized 484 equipment that is not standard in a laboratory that performs multielectrode recordings in 485 behaving rats. Indeed, a major advantage over iontophoresis is that the present technique 486 utilizes multiple electrodes to maximize the experimental yield. Although a previous study 487 employed pressure injections lateral to a linear array of electrodes in the brains of awake rats 488 (Krupa et al. 1999) , our configuration situates the electrodes equidistant from the injection 489 cannula, resulting in nearly simultaneous drug effects at all recorded neurons. Furthermore, our 490 design incorporates a microdrive so that new neuronal populations can be repeatedly sampled 491 in the same animal. Importantly, our design results in physical parameters (e.g., distances 492 between electrodes and cannula; drive dimensions) that are highly reproducible across 493 constructed systems, in part because of the use of a jig to position the electrodes and cannula, 494 and in part because of the use of precision stereolithography to produce custom-designed 495 plastic parts for the microdrive. Because the jig and drive components are inexpensive, our 496 system minimizes cost while maximizing consistency and ease of construction and use. Its 497 success with lidocaine injections in the NAc suggests that it could be used in a variety of brain 498 structures to inject many different drugs. Moreover, because of its light weight, the system is 499 suitable for use in mice and other small animals. Finally, with slight modification, the central 500 cannula could also accommodate a fiber optic cable for light activation of neurons expressing 501 light-sensitive ion channels. 502
In summary, we developed a novel drivable cannulated electrode array that facilitates robust 503 and quantitatively reproducible drug effects on ensembles of single neurons recorded with 504 multiple electrodes in the brain of awake, unrestrained rats. Lidocaine injection experiments 505 suggest that it could also be used to deliver agonists and antagonists of neurotransmitter 506 receptors, providing a reliable means to study the contribution of neurotransmitters to 507 behaviorally relevant neural activity. 508 for the behavioral and nucleus accumbens neuronal firing responses to incentive cues. 637
The Example action potential waveforms from 2 neurons before, during and after saline injections. E. 682
Proportions of all neurons significantly affected and unaffected by lidocaine and saline 683 injections. The criterion for injection effect was that 6 consecutive 10 sec bins exhibited spike 684 counts that were below the 99% confidence interval of the baseline firing rate. F. Recovery was 685 complete in most neurons. Graph shows the distribution of firing rates in the last recorded 1 min 686 bin normalized to the pre-injection baseline for all 100 neurons affected by lidocaine. Dashed 687 grey lines encompass those neurons that recovered to within the 95% confidence interval of 688 their pre-injection baseline firing rates (computed from 1 min bins). 689 Neurons that were recorded on the same (gray) or different (black) electrode from the reference 701 neuron are compared. 702 
